Abstract
In this issue of Blood, Papadopoulos et al(1) reveal that oncogenic JAK2V617F elicits a unique pattern of active human thrombopoietin receptor (hTpoR)......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
